232.40↑0.00 (0.00%)
03:31 PM,6th Dec 2023↑ (%)
BSE : 535434
NSE : MADHAVBAUG
Sector : Others
ISIN Code : INE0JR301013
Market Cap (₹ Cr) | 244 |
Turnover (₹ Cr) | 0.04 |
Volume (Shares) | 16800 |
Face Value | 10 |
52-WK High | 376.95 |
52-WK High Date | 24 Aug 2023 |
52-WK Low | 135.10 |
52-WK Low Date | 05 Dec 2022 |
All Time High | 376.95 |
All Time High Date | 24 Aug 2023 |
All Time Low | 98.00 |
All Time Low Date | 23 Feb 2022 |
The Company was originally incorporated as a Private Limited Company under the Companies Act 1956 pursuant to a Certificate of Incorporation issued by the Registrar of Companies Pune dated April 6 1999 with the name `Vaidya Sane Ayurved Laboratories Private Limited'. Subsequently Company was converted into to a Public Limited Company and the name of Company was changed to `Vaidya Sane Ayurved Laboratories Limited' by a Special Resolution passed on November 19 2021. A fresh Certificate of Incorporation consequent upon conversion was issued on November 25 2021 by the Registrar of Companies Pune. Dr. Rohit Madhav Sane is the Present Promoter of the Company.The Company is a unique medical service institution that strives to treat chronic ailments like cardiac disease diabetes hypertension and obesity with the distinctive outlook of amalgamating technology with traditional healing of Ayurveda. Its approach to treatment using non-invasive multidisciplinary and innovative therapies which has helped establish the Company as a dependable option for treating the chronic ailments.The Company is primarily engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurvedic medical professional services across its various clinics including panchkarma and other ayurvedic treatments through running of ayurvedic Hospital.The Company is a health care provider primarily in the India's chronic care ecosystem. The Company provide healthcare services through Madhavbaug clinics. It operate 274 clinics across Maharashtra Madhya Pradesh Gujarat Uttar Pradesh Goa and Karnataka. Out of these 52 are company owned and 222 are franchise clinics. The Company also operate two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively. Currently the Company has a network including 274 Clinics and 2 Fully equipped Hospital.The Company has entered into MOU dated April 1 2019 with Vaidya Sane's Ayurvedic Education And Agricultural Research Trust for the entire management medical services and treatments being carried out at Khopoli Hospital. The Company use clinic based health care delivery model along with tele-medicine to ensure easy accessibility to patients. Apart from treatments as a means of raising awareness about disease and its associated complications the Company conduct a number of workshops support events etc. with a singular objective of helping patients manage their chronic non-communicable conditions more effectively as well.At Madhavbaug clinics and hospitals the Company use modern diagnostics diet and physiotherapy and advanced Ayurveda to provide Heart disease Diabetes Hypertension & Obesity reversal treatments to our patients. This helps in improving the exercise tolerance of patients - improvement in grade of symptoms improvement in maximum oxygen uptake reduction in Hba1c and metabolic equivalents (METs). In 2006 First Cardiac Prevention and Rehabilitation Hospital was set up at Khopoli and inaugurated opening of first Madhavbaug Clinic at Dombivili Maharashtra.In 2009 the Company established in house research and development team at Thane.In 2012 the Company established the First Cardiac Prevention and Rehabilitation Hospital at Nagpur.In 2013 the Company inaugurated opening of 100th Madhavbaug Clinic at Kankavli in Ratnagiri.In 2014 the Company launched Arogyam Hriday Sampada with a Mission to create awareness of heart disease.In 2015 the Company launched therapies for risk factors such as diabetes obesity and hypertension at Madhavbaug Clinics.In 2016 the Company launched a research based disease wise diet kits at Madhavbaug Clinics for aiding healthcare programmes and established Madhavbaug Institute of Preventive Cardiology with MUHS. These kits aid in the recovery and rehabilitation of its patients.In 2017 Madhavbaug Clinics received Frost and Sullivan's 2017 India Best Practices Award and the Company's randomized controlled trial by Madhavbaug was published in Indian Heart Journal Official publication of Cardiological Society of India.In 2018 Madhavbaug Clinics ventured into India Book of Records for conducting GTT of 661 diabetic patients in single day at 13 different locations. The Company participated as main sponsor of World Ayurved Congress 2018 held in Ahmedabad. Apart from this the Company inaugurated the opening of 200th Madhavbaug Clinic at Nanded in Maharashtra. In 2019 Madhavbaug introduced research based heart blockage management program. The Company achieved new registrations of over 90000 patients and more than 27000 stress tests were conducted and over 300000 panchakarma procedures performed.In 2020 the Company launched MIB Pulse Mobile Application for patient engagement.In 2021 the Company inaugurated the opening of 250th Madhavbaug Clinic at Vashi. The Company's conducted Research trial on one year follow-up of diabetes patients treated by Madhavbaug was published in Journal of Association of Physicians of India. The Company achieved MIB Pulse Mobile Application over 100000 downloads which was developed by a third-party vendor. It calculated the risk of getting a heart attack by considering risk factors that a person has and also gave tips on how to reduce & manage the risk. The Company has also launched online portal www.madhavbaugwellness.com for new wellness products such as Madhav ShaktiAtta apple cider vinegar prosix dosa mix nutriboom ghavan mix digy smooth moong daliya lentigrain idli mix Insta health thalli peeth power mix muthiya aata diaphragm kadha arj kadha groundnut oil amla lichi syrup etc. and many more.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 244 |
EPS - TTM (₹) [S] | 4.94 |
P/E Ratio (X) [S] | 5.99 |
Face Value (₹) | 10 |
Latest Dividend (%) | 2.50 |
Latest Dividend Date | 05 Sep 2023 |
Dividend Yield (%) | 0.11 |
Book Value Share (₹) [S] | 38.82 |
P/B Ratio (₹) [S] | 5.99 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 231.25 245.00 |
Year Low/High | 135.10 377.00 |
All time Low/High | 0.00 377.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | % | % | 3.60 | 3.73% |
1 Month | % | % | 6.86 | 7.61% |
3 Month | % | % | 4.73 | 5.86% |
6 Month | % | % | 10.52 | 12.28% |
1 Year | % | % | 11.20 | 12.51% |
3 Year | % | % | 52.77 | 56.36% |
Managing Director & CEO : Rohit Madhav Sane
Whole-time Director : Vidyut Bipin Ghag
Independent Director : Ratnakar Venkappa Rai
Independent Director : Sushrut Raghavendra Dambal
Independent Director : Mahesh P. Kshirsagar
Company Sec. & Compli. Officer : Abhishek Ajay Deshpande
Registered Office: 201 B Bhoomi Velocity Road, No.23 Above ICICI Bank Thane(W,Thane,Maharashtra-400604 Ph: 91-7738070019
Email:cs@madhavbaug.com